Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Shares Outstanding (Diluted Average): 2018-2025

Historic Shares Outstanding (Diluted Average) for Organogenesis Holdings (ORGO) over the last 6 years, with Sep 2025 value amounting to $130.8 million.

  • Organogenesis Holdings' Shares Outstanding (Diluted Average) fell 2.30% to $130.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.8 million, marking a year-over-year decrease of 2.30%. This contributed to the annual value of $131.7 million for FY2024, which is 0.81% down from last year.
  • Organogenesis Holdings' Shares Outstanding (Diluted Average) amounted to $130.8 million in Q3 2025, which was down 2.30% from $133.9 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Shares Outstanding (Diluted Average) ranged from a high of $134.0 million in Q2 2021 and a low of $126.3 million during Q1 2025.
  • Over the past 3 years, Organogenesis Holdings' median Shares Outstanding (Diluted Average) value was $132.6 million (recorded in 2024), while the average stood at $131.9 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first increased by 27.96% in 2021, then dropped by 4.22% in 2025.
  • Organogenesis Holdings' Shares Outstanding (Diluted Average) (Quarterly) stood at $133.7 million in 2021, then decreased by 0.96% to $132.4 million in 2022, then grew by 0.27% to $132.7 million in 2023, then declined by 0.81% to $131.7 million in 2024, then dropped by 2.30% to $130.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $130.8 million in Q3 2025, compared to $133.9 million in Q2 2025 and $126.3 million in Q1 2025.